The use of adenoviral vectors in gene therapy and vaccine approaches

The use of adenoviral vectors in gene therapy and vaccine approaches

Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...

Descripció completa

Dades bibliogràfiques
Autors principals:	Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura
Format:	Article
Idioma:	English
Publicat:	Sociedade Brasileira de Genética 2022-10-01
Col·lecció:	Genetics and Molecular Biology
Matèries:	Adenovirus gene therapy monogenic diseases cancer vaccines
Accés en línia:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en

Ítems similars

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
per: Jingao Guo, et al.
Publicat: (2018-07-01)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
per: Lynda Coughlan
Publicat: (2020-05-01)

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
per: Luca Scarsella, et al.
Publicat: (2024-02-01)

Improving adenoviral vectors and strategies for prostate cancer gene therapy
per: Rodrigo Esaki Tamura, et al.
Publicat: (2018-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
per: L. V. Cherenova, et al.
Publicat: (2017-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
per: L. V. Cherenova, et al.
Publicat: (2017-05-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
per: Meirong Wang, et al.
Publicat: (2021-03-01)

Progress in Adenoviral Capsid-Display Vaccines
per: Marija Vujadinovic, et al.
Publicat: (2018-07-01)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
per: Alessandra Vitelli, et al.
Publicat: (2017-12-01)

Adenoviral vectors for gene therapy /
per: Curiel, David T., et al.
Publicat: (2002)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
per: César López-Camacho, et al.
Publicat: (2020-06-01)

Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
per: Mirian Galliote Morale, et al.
Publicat: (2022-02-01)

Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines
per: John Benest, et al.
Publicat: (2020-03-01)

A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates
per: José M. Rojas, et al.
Publicat: (2021-09-01)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
per: Vidthiya Jeyanathan, et al.
Publicat: (2022-06-01)

Construction and application of adenoviral vectors
per: Hongbo Zhang, et al.
Publicat: (2023-12-01)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
per: Qiwei Zhang, et al.
Publicat: (2022-03-01)

The Role of Chromatin in Adenoviral Vector Function
per: Carmen M. Wong, et al.
Publicat: (2013-06-01)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
per: Vidthiya Jeyanathan, et al.
Publicat: (2023-02-01)

Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus
per: Erika M. Petro-Turnquist, et al.
Publicat: (2022-06-01)

Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations
per: Omar Farnós, et al.
Publicat: (2023-12-01)

Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route
per: Sara Afrough, et al.
Publicat: (2020-03-01)

Single-cycle adenovirus vectors in the current vaccine landscape
per: Michael Barry
Publicat: (2018-02-01)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
per: Wen-Chien Wang, et al.
Publicat: (2022-12-01)

Adenoviral Keratoconjunctivitis
per: Alexander Bialasiewicz
Publicat: (2007-04-01)

Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents
per: Joshua Del Papa, et al.
Publicat: (2017-01-01)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
per: Dulce Mata-Espinosa, et al.
Publicat: (2023-10-01)

TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line
per: Mirian Galliote Morale, et al.
Publicat: (2022-04-01)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
per: Catherine Collignon, et al.
Publicat: (2020-11-01)

Developments in Viral Vector-Based Vaccines
per: Takehiro Ura, et al.
Publicat: (2014-07-01)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
per: Cal Koger-Pease, et al.
Publicat: (2023-02-01)

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes
per: Groitl Peter, et al.
Publicat: (2011-09-01)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
per: Andrew H. Baker, et al.
Publicat: (2010-10-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
per: Adam Berg, et al.
Publicat: (2021-10-01)

Current development in adenoviral vectors for cancer immunotherapy
per: Greyson Willis Grossman Biegert, et al.
Publicat: (2021-12-01)

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies
per: Chinonyerem O. Iheanacho, et al.
Publicat: (2022-03-01)

The prevalence of adenoviral conjunctivitis at the Clinical Hospital of the State University of Campinas, Brazil
per: Roberto Damian Pacheco Pinto, et al.
Publicat: (2015-11-01)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
per: Heikki Saari, et al.
Publicat: (2020-01-01)

Application of adenovirus vector in cancer gene therapyand vaccination
per: Xie Qian, et al.
Publicat: (2021-03-01)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
per: Senthil K. Chinnakannan, et al.
Publicat: (2020-04-01)